You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Professional Issues Articles
Popular Professional Issues Articles
Highly Recommended Professional Issues Articles
Send a link to this page to your friends and colleagues.
Researchers at the University Clinic for Internal Medicine in Innsbruck, Austria, obtained data from a patient population of 678 patients with type 2. The patients were not able to adequately control their type 2 with oral medications alone. Patients received either Lantus in addition to oral therapy or were switched to conventional insulin therapy and were followed for two to four months.
The researchers say the two therapeutic regimens were equally effective in decreasing A1C. Total daily costs of insulin, needles, blood glucose-monitoring devices (such as meters and test strips) and oral meds per patient were similar in the two treatment groups, amounting in American dollars to about $2.31 per day in the Lantus group versus $2.41 per day in the conventional group.
“The two treatment regimens were equally effective in improving [blood glucose] control,” say the researchers. “These results were achieved with significantly lower insulin doses and fewer blood glucose test strips in the [Lantus] group, which therefore led to cost equivalence when compared with conventional insulin therapy.”
—Wiener klinische Wochenschrift, September 2005
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.